Acicvir, also commonly known as Acyclovir, is a synthetic purine nucleoside analogue. Studies on cell cultures have proven its great anti-viral potential against such viruses as human herpes virus, varicella zoster virus, Epstein Barr virus or cytomegalovirus, against which it takes very effective in vitro and vivoinhibitory actions.

Acicvir Indications

The primary use for Acicvir is to inhibit and stop the production of herpes virus, its actions limiting the effects of herpes virus outbreaks in length and severity, on mucous membranes or skin. Its usage is also recommended in treating recurring genital herpes, Shingles or herpes zoster infections. Acicvir can be prescribed for patients with severe AIDS (with CD4 count of under 50 per micro liter) or for patients that undergo operations such as allogenic bone marrow transplant.

Acicvir Warnings

Extra precaution is are to be taken by patients with wounds or open lesions, due to easier transmission of the infections.
Although Acicvir has no known adverse effect on fertility, its use by pregnant or nursing women may be hazardous due to its tendency to pass into the breast milk. Therefore, prior consulting with your doctor is recommended in such cases.
Also, Acicvir may not be recommended to patients suffering from liver, kidney or brain disorders.

Acicvir Intake Guidelines

While following a treatment with Acicvir, the patient must follow the exact instructions that the doctor has given him. Each dose of the drug should be accompanied by a glass of water. Consumption of plenty of fluids may also be advised to patients under Acicvir treatment.

Acicvir Dosage

The correct dosage of Acicvir should be obtained by the patient’s personal doctor, because the suitable dosage of the drug depends on several factors. It can vary from 200 mg 5 times per day (Herpex simplex infections, double dosage for patients with a greater risk of vulnerability, such as patients with recent history of bone marrow transplant), 200 mg every 6 hours (or 400 mg every 12 hours), in cases of satisfactory immunity. It is advised to interrupt Acicvir treatment at a 6-12 month interval, to examine the changes in the disease history and for monitoring the virus patterns.